pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,831
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
GFH-375
Colorectal Cancer
$VSTM
Verastem, Inc.
0
catalysts
Preclinical
GH-3595
Solid Tumor
Suzhou GenHouse Pharmaceutical Co Ltd
0
catalysts
Phase 2
GI-102
Metastatic Melanoma
GI Innovation Co Ltd
0
catalysts
Phase 1
GIGA-564
Solid Tumor
← prev
page 20 of 62
next →
131
Pain
89
Neurology
1
GigaGen Inc
0
catalysts
Phase 2
GIM-122
Solid Tumor
Georgiamune Inc
0
catalysts
Phase 2
GIM-531
Metastatic Melanoma
Georgiamune Inc
0
catalysts
Phase 2
GLIX-1
High-Grade Glioma
Tetragon Biosciences Ltd
0
catalysts
Preclinical
GLR-2007
Malignant Glioma
Gan & Lee Pharmaceuticals Co Ltd
0
catalysts
Preclinical
GNTbm-TKI
Neuroendocrine Tumors
Great Novel Therapeutics Biotech & Medicals Corp
0
catalysts
Phase 2
GO-2032c
Refractory Acute Myeloid Leukemia
Genus Oncology LLC
0
catalysts
Phase 3
GP-2
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast…
Vascular endothelial growth factor A, long form
$GLSI
Greenwich LifeSciences, Inc.
0
catalysts
Phase 2
GRC-54276
Bile Duct Cancer (Cholangiocarcinoma)
Ichnos Glenmark Innovation
0
catalysts
Phase 1
GRN-300
Triple-Negative Breast Cancer (TNBC)
Greenfire Bio LLC
0
catalysts
Phase 1
GS-0321
Solid Tumor
$GILD
GILEAD SCIENCES, INC.
0
catalysts
Phase 2
GSK-101
Human Epidermal Growth Factor Receptor 2 Low Breast Cancer (HER2 Low Breast C…
Sodium channel protein type 9 subunit alpha
$GSK
GSK plc
0
catalysts
Phase 1
GTB-3650
Myelodysplastic Syndrome (Preleukemia)
$GTBP
GT Biopharma, Inc.
0
catalysts
Phase 1
GTB-5550
Epithelial Ovarian Cancer
$GTBP
GT Biopharma, Inc.
0
catalysts
Phase 2
GV-200251
Cervical Cancer
GV20 Therapeutics LLC
0
catalysts
Preclinical
GW-01
Unspecified Cancer
Groovy Medicine Inc
0
catalysts
Phase 1
Gallium Maltolate
Recurrent Glioblastoma Multiforme (GBM)
$KMCM
Titan Holdings Corp.
0
catalysts
Preclinical
Gene Therapy to Target BCMA and CS1 for Multiple Myeloma
Multiple Myeloma (Kahler Disease)
University of California Los Angeles
0
catalysts
Phase 1
Gene Therapy to Target CD22 for Oncology
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
National Cancer Institute US
0
catalysts
Preclinical
GlyTR1 Bi-specific Protein
Solid Tumor
GlyTR Therapeutics Inc
0
catalysts
Phase 2
H-002
Non-Small Cell Lung Cancer
RedCloud Bio Inc
0
catalysts
Phase 1
H-3B6545
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Eisai Co Ltd
0
catalysts
Phase 1
HBM-1020
Metastatic Colorectal Cancer
Harbour BioMed (Guangzhou) Co Ltd
0
catalysts
Phase 1
HCB-301
Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma)
HanchorBio Inc
0
catalysts
Phase 2
HCW-9218
Metastatic Pancreatic Cancer
$HCWB
HCW Biologics Inc.
0
catalysts
Phase 1
HF-158K1
Bladder Cancer
HighField Biopharmaceuticals, Inc.
0
catalysts
Phase 1
HFB-200603
Colorectal Cancer
HiFiBiO Therapeutics Inc
0
catalysts
